Prior studies have already described that dysregulation of LSD1 can influence cancer development: Overexpression of LSD1 correlates with poor prognosis in various cancer types like bladder cancer (Hayami et al. 2011), colon cancer (Jie et al. 2013) or hepatocellular carcinoma (Kim et al. 2019). This evidence concerns the gene KDM1A and malignant colon neoplasm.